Wednesday, November 26, 2014

Subscribe to the IP Headline RSS feed | Subscribe to the IP Headline feed via Email

Supreme Court Remands Isolated DNA Patent Challenge for Review in Light of Mayo Case Decision

A week after its surprising unanimous decision rejecting method claim patent eligibility, the U.S. Supreme Court on March 26 remanded to the U.S. Court of Appeals for the Federal Circuit the case testing whether patent claims on isolated DNA are patent eligible subject matter under Section 101 of the Patent Act, 35 U.S.C. §101 (Association for Molecular Pathology v. Myriad Genetics Inc., U.S., No. 11-725, remanded 3/26/12). …

  1. Read this entire article for free, simply activate your free 7 day trial access now.
Contact Bloomberg BNA
  1. (required)
  2. (valid email required)
  3. Captcha
 

cforms contact form by delicious:days

Tweet this!Tweet this!